Projecting the 30% rate increase through 2014 the total is $217.1M. Very possible when you factor in 25 new sales representatives, ASA, new health care coverage, $50M milestone.
Something to think about and track! The potential certainly is there! The next 14 months will be most interesting. Considering this one drug has blockbuster potential out of several other potential candidates in their pipeline and SNTS is a stand-out candidate.